Novartis Investigative Site

Buxtehude, Lower Saxony 21614

0 studies enrolling now · 2 studies all time

What they study most

Melanoma

Studies at this site

• Dabrafenib Plus Trametinib vs Vemurafenib Alone in Unresectable or Metastatic BRAF V600E/K Cutaneous Melanoma — Completed
• A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma — Completed